(VIANEWS) – Novo Nordisk A/S (NVO), Celanese (CE), National Oilwell Varco (NOV) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Novo Nordisk A/S (NVO)
24.1% sales growth and 72% return on equity
Stocks recently featured in the blog include: Amazon.com, Inc. (AMZN Quick QuoteAMZN – Free Report) , Novo Nordisk A/S (NVO Quick QuoteNVO – Free Report) , Qualcomm Inc. (QCOM Quick QuoteQCOM – Free Report) , Booking Holdings Inc. (BKNG Quick QuoteBKNG – Free Report) and Chubb Ltd. , Today’s Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc., Novo Nordisk A/S and Qualcomm Inc..
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Earnings Per Share
As for profitability, Novo Nordisk A/S has a trailing twelve months EPS of $2.92.
PE Ratio
Novo Nordisk A/S has a trailing twelve months price to earnings ratio of 51.27. Meaning, the purchaser of the share is investing $51.27 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 72%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Mar 23, 2023, the estimated forward annual dividend rate is 1.77 and the estimated forward annual dividend yield is 1.27%.
Volume
Today’s last reported volume for Novo Nordisk A/S is 1226650 which is 14.55% below its average volume of 1435520.
Previous days news about Novo Nordisk A/S(NVO)
- According to Zacks on Monday, 20 March, "Some top-ranked stocks in the Medical space are Amphastar Pharmaceuticals, Inc. (AMPH Quick QuoteAMPH – Free Report) , Novo Nordisk A/S (NVO Quick QuoteNVO – Free Report) and Henry Schein, Inc. (HSIC Quick QuoteHSIC – Free Report) . "
2. Celanese (CE)
18.2% sales growth and 34.92% return on equity
Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through three segments: Engineered Materials, Acetate Tow, and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics. It also offers acesulfame potassium, a sweetener for use in various beverages, confections, and dairy products; and food protection ingredients, such as potassium sorbate and sorbic acid for use in foods, beverages, and personal care products. The Acetate Tow segment provides acetate tows and flakes for use in filter products applications. The Acetyl Chain segment produces and supplies acetyl products, including acetic acid, vinyl acetate monomers, acetic anhydride, and acetate esters that are used as starting materials for colorants, paints, adhesives, coatings, and pharmaceuticals; and organic solvents and intermediates for pharmaceutical, agricultural, and chemical products. It also offers vinyl acetate-based emulsions for use in paints and coatings, adhesives, construction, glass fiber, textiles, and paper applications; and ethylene vinyl acetate resins and compounds, as well as low-density polyethylene for use in flexible packaging films, lamination film products, hot melt adhesives, automotive parts, and carpeting applications. In addition, it manufactures ultra-high molecular weight polyethylene. Celanese Corporation was founded in 1918 and is headquartered in Irving, Texas.
Earnings Per Share
As for profitability, Celanese has a trailing twelve months EPS of $17.84.
PE Ratio
Celanese has a trailing twelve months price to earnings ratio of 5.59. Meaning, the purchaser of the share is investing $5.59 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.92%.
Previous days news about Celanese(CE)
- According to Zacks on Tuesday, 21 March, "DuPont completed the divestment of the majority of its Mobility & Materials unit to Celanese on Nov 1, 2022 as part of its ongoing transformation."
3. National Oilwell Varco (NOV)
17.4% sales growth and 3.04% return on equity
National Oilwell Varco, Inc. designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production worldwide. It operates through three segments: Wellbore Technologies, Completion & Production Solutions, and Rig Technologies. The company offers various equipment and technologies used to perform drilling operations. It also provides solids control and waste management equipment and services; drilling fluids; portable power generation products; drill and wired pipes; drilling optimization and automation services; tubular inspection, repair, and coating services; instrumentation, and measuring and monitoring services; downhole and fishing tools; steerable technologies; and drill bits. The company offers equipment and technologies for hydraulic fracture stimulation, including pressure pumping trucks, blenders, sanders, hydration units, injection units, flowline, and manifolds; well intervention, such as coiled tubing units, coiled tubing, and wireline units, as well as blowout preventers and tools; onshore production comprising fluid processing systems, composite pipes, surface transfer and progressive cavity pumps, and artificial lift systems; offshore production that include fluid processing systems, floating production systems, and subsea production technologies; and connectors for conductor pipes. It also provides substructures, derricks, and masts; cranes; jacking systems; pipe lifting, racking, rotating, and assembly systems; mud pumps; blowout preventers; drives and generators; rig instrumentation and control systems; equipment components for offshore wind construction vessels; mooring, anchor, and deck handling machinery; and pipelay and construction systems. The company offers spare parts, repair, and rentals, as well as remote equipment monitoring, technical support, field service, and customer training services. National Oilwell Varco, Inc. was founded in 1862 and is based in Houston, Texas.
Earnings Per Share
As for profitability, National Oilwell Varco has a trailing twelve months EPS of $-1.59.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.04%.
Yearly Top and Bottom Value
National Oilwell Varco’s stock is valued at $20.20 at 16:22 EST, way below its 52-week high of $24.83 and way higher than its 52-week low of $13.98.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Dec 7, 2022, the estimated forward annual dividend rate is 0.2 and the estimated forward annual dividend yield is 0.86%.
4. Coca Cola Femsa S.A.B. de C.V. (KOF)
15.4% sales growth and 15.13% return on equity
Coca-Cola FEMSA, S.A.B. de C.V., a franchise bottler, produces, markets, sells, and distributes Coca-Cola trademark beverages. The company offers sparkling beverages, including colas and flavored sparkling beverages; and waters and still beverages, such as juice drinks, coffee, teas, milk, value-added dairy products, sports drinks, energy drinks, and plant-based drinks. It provides a portfolio of products through retail outlets, such as wholesale supermarkets, discount stores, and convenience stores; retailers, such as restaurants and bars, as well as stadiums, auditoriums, and theaters; points-of-sale outlets; and home delivery and other locations. The company also distributes and sells Heineken beer products in its Brazilian territories. It operates in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Brazil, Argentina, and Uruguay. Coca-Cola FEMSA, S.A.B. de C.V. was founded in 1979 and is based in Mexico City, Mexico. Coca-Cola FEMSA, S.A.B. de C.V. is a subsidiary of Fomento Economico Mexicano, S.A.B. de C.V.
Earnings Per Share
As for profitability, Coca Cola Femsa S.A.B. de C.V. has a trailing twelve months EPS of $4.93.
PE Ratio
Coca Cola Femsa S.A.B. de C.V. has a trailing twelve months price to earnings ratio of 15.42. Meaning, the purchaser of the share is investing $15.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.13%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Oct 30, 2022, the estimated forward annual dividend rate is 2.72 and the estimated forward annual dividend yield is 3.53%.
5. BayCom Corp (BCML)
13.4% sales growth and 9.31% return on equity
BayCom Corp operates as the bank holding company for United Business Bank that provides various financial services to businesses, business owners, and individuals. The company offers demand, savings, money market, and time deposit accounts. It also provides commercial and multifamily real estate loans, including owner-occupied and investor real estate loans; commercial and industrial loans, such as equipment loans and working capital lines of credit; small business administration loans; construction and land loans; agriculture-related loans; and consumer loans comprising installment loans, unsecured and secured personal lines of credit, and overdraft protection. In addition, the company offers online and mobile banking, automated teller machine, remote deposit capture, night depository, courier, direct deposit, treasury management, wire transfer, automated clearing house services, debit cards, cashier's and travelers checks, letters of credit, lockbox, positive pay, reverse positive pay, account reconciliation, and escrow services, as well as facilitates tax-deferred commercial exchanges and provides zero balance accounts and sweep accounts including loan sweep. It operates through a network of 34 full service branches in Northern and Southern California; Denver, Colorado; Custer, Delta, and Grand counties, Colorado; and Seattle, Washington and Central New Mexico. The company was formerly known as Bay Commercial Bank and changed its name to BayCom Corp in January 2017. BayCom Corp was founded in 2004 and is headquartered in Walnut Creek, California.
Earnings Per Share
As for profitability, BayCom Corp has a trailing twelve months EPS of $2.06.
PE Ratio
BayCom Corp has a trailing twelve months price to earnings ratio of 8.75. Meaning, the purchaser of the share is investing $8.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.31%.
Sales Growth
BayCom Corp’s sales growth is 17.5% for the present quarter and 13.4% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 15.7% and 60.5%, respectively.
Volume
Today’s last reported volume for BayCom Corp is 46578 which is 33.27% above its average volume of 34949.
6. BioMarin Pharmaceutical (BMRN)
12.9% sales growth and 3.19% return on equity
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops valoctocogene roxaparvovec, an adeno associated virus vector, which is in Phase III clinical trial for the treatment of patients with severe hemophilia A; BMN 307, an AAV5 mediated gene therapy, which is in Phase 1/2 clinical trial to normalize blood Phe concentration levels in patients with PKU; and BMN 255 that is in Phase 1/2 clinical trial for treating primary hyperoxaluria. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc., and Asubio Pharma Co., Ltd. The company was incorporated in 1996 and is headquartered in San Rafael, California.
Earnings Per Share
As for profitability, BioMarin Pharmaceutical has a trailing twelve months EPS of $0.72.
PE Ratio
BioMarin Pharmaceutical has a trailing twelve months price to earnings ratio of 125.35. Meaning, the purchaser of the share is investing $125.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.19%.
7. Heartland Financial USA (HTLF)
11% sales growth and 10.83% return on equity
Heartland Financial USA, Inc., a multi-bank holding company, provides commercial, small business, and consumer banking products and services to individuals and businesses in the United States. It accepts various deposit products, including checking and other demand deposit accounts; NOW, savings, money market, and individual retirement accounts; certificates of deposit; and other time deposits. The company also offers commercial and industrial loans; commercial real estate and real estate mortgage loans; small business loans; agricultural loans; consumer loans comprising motor vehicle and home improvement loans, home equity line of credit, and fixed rate home equity and personal lines of credit; and credit cards for commercial, business, and personal use, as well as debit cards. In addition, it provides online banking, mobile banking, telephone banking, bill payment, automated clearing house, wire transfer, zero balance account, transaction reporting, lock box, remote deposit capture, accounts receivable, commercial purchasing card, investment sweep account, reconciliation, treasury management, foreign exchange, and various fraud prevention services, such as check and electronic positive pay, and virus/malware protection services, as well as automated teller machines. Further, the company offers investment services, such as mutual funds, annuities, retirement products, education savings products, and brokerage services, as well as vehicle, property and casualty, and life and disability insurance products. Additionally, it is involved in the community development, consumer finance, multi-line insurance agency, and property management businesses. The company operates through 133 banking locations in Iowa, Illinois, Wisconsin, New Mexico, Arizona, Montana, Colorado, Minnesota, Kansas, Missouri, Texas, and California. Heartland Financial USA, Inc. was founded in 1981 and is headquartered in Dubuque, Iowa.
Earnings Per Share
As for profitability, Heartland Financial USA has a trailing twelve months EPS of $4.86.
PE Ratio
Heartland Financial USA has a trailing twelve months price to earnings ratio of 8.22. Meaning, the purchaser of the share is investing $8.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.83%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.9%, now sitting on 707.14M for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Feb 8, 2023, the estimated forward annual dividend rate is 1.2 and the estimated forward annual dividend yield is 3.04%.
Sales Growth
Heartland Financial USA’s sales growth is 14.8% for the present quarter and 11% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 39.2% and 16.2%, respectively.
8. Royal Gold (RGLD)
8.5% sales growth and 8.96% return on equity
Royal Gold, Inc., together with its subsidiaries, acquires and manages precious metal streams, royalties, and related interests. It focuses on acquiring stream and royalty interests or to finance projects that are in production or in development stage in exchange for stream or royalty interests, which primarily consists of gold, silver, copper, nickel, zinc, lead, and cobalt. As of June 30, 2021, the company owned interests in 187 properties on five continents, including interests on 41 producing mines and 17 development stage projects. Its stream and royalty interests on properties are located in the United States, Canada, Chile, the Dominican Republic, Australia, Africa, Mexico, and internationally. Royal Gold, Inc. was incorporated in 1981 and is headquartered in Denver, Colorado.
Earnings Per Share
As for profitability, Royal Gold has a trailing twelve months EPS of $3.78.
PE Ratio
Royal Gold has a trailing twelve months price to earnings ratio of 33.19. Meaning, the purchaser of the share is investing $33.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.96%.
